临床医生如何解读Meta分析论文?

2021-05-30 朱熠冰,李卫 协和医学杂志

Meta分析是翻译自英文meta-analysis,其中“Meta”一词源于古希腊文,意指将事物综合起来观察。

Meta分析是翻译自英文meta-analysis,其中“Meta”一词源于古希腊文,意指将事物综合起来观察。 Meta分析的概念最早由Light和Smoth于1971年提出,是一种对不同研究结果进行合并分析的方法[1-2]。 在医学研究中,Meta分析常用于研究结果的合并,最常见的是随机对照试验(RCT)结果的合并,该方法逐渐发展为循证医学的主要研究手段之一。 Meta分析的基本步骤: (1)明确研究问题 (2)制定检索策略 (3)筛选纳入文献 (4)提取数据信息 (5)评估研究质量和偏倚风险 (6)采用Meta分析方法合并数据报告结果[1]。 2009年的一项报告显示,每年新发表的系统综述数量在2500篇以上,其中1/3为Meta分析,此后10年的发表速度提高了近10倍 [3-5]。系统综述和Meta分析汇总医疗行为的获益与危害证据,为医疗决策提供依据。 随着循证医学的发展,通过阅读Meta分析获取前沿信息已成为临床医生必须掌握的一项重要技能[3]。但Meta分析质量良莠不齐,其结果和结论能否直接应用于临床,需进行鉴别和评估,这对读者提出了更高要求。 Meta分析文献是对Meta分

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1896848, encodeId=9f1c18968484d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon Sep 27 08:49:42 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888304, encodeId=9efb188830446, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon Mar 14 04:49:42 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978618, encodeId=9ab39e8618a1, content=不懂mate分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Thu Jul 01 14:46:39 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554816, encodeId=bb2e155481690, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Tue Jun 01 07:49:42 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969850, encodeId=59549698503f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02972000979, createdName=walking, createdTime=Mon May 31 14:06:45 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969743, encodeId=d247969e435d, content=忘了好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6515442859, createdName=ms2000000817442249, createdTime=Mon May 31 00:27:41 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969661, encodeId=f4b9969661d2, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>欢迎加群一起探讨学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/4dcd194e80b140debd1d7d6c161b3f13/7d140f158faa42adaa5ff6054058df7d.jpg, createdBy=216b5484325, createdName=一颗小芃友, createdTime=Sun May 30 17:23:48 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-09-27 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1896848, encodeId=9f1c18968484d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon Sep 27 08:49:42 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888304, encodeId=9efb188830446, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon Mar 14 04:49:42 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978618, encodeId=9ab39e8618a1, content=不懂mate分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Thu Jul 01 14:46:39 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554816, encodeId=bb2e155481690, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Tue Jun 01 07:49:42 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969850, encodeId=59549698503f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02972000979, createdName=walking, createdTime=Mon May 31 14:06:45 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969743, encodeId=d247969e435d, content=忘了好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6515442859, createdName=ms2000000817442249, createdTime=Mon May 31 00:27:41 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969661, encodeId=f4b9969661d2, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>欢迎加群一起探讨学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/4dcd194e80b140debd1d7d6c161b3f13/7d140f158faa42adaa5ff6054058df7d.jpg, createdBy=216b5484325, createdName=一颗小芃友, createdTime=Sun May 30 17:23:48 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2022-03-14 guojianrong
  3. [GetPortalCommentsPageByObjectIdResponse(id=1896848, encodeId=9f1c18968484d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon Sep 27 08:49:42 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888304, encodeId=9efb188830446, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon Mar 14 04:49:42 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978618, encodeId=9ab39e8618a1, content=不懂mate分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Thu Jul 01 14:46:39 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554816, encodeId=bb2e155481690, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Tue Jun 01 07:49:42 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969850, encodeId=59549698503f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02972000979, createdName=walking, createdTime=Mon May 31 14:06:45 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969743, encodeId=d247969e435d, content=忘了好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6515442859, createdName=ms2000000817442249, createdTime=Mon May 31 00:27:41 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969661, encodeId=f4b9969661d2, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>欢迎加群一起探讨学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/4dcd194e80b140debd1d7d6c161b3f13/7d140f158faa42adaa5ff6054058df7d.jpg, createdBy=216b5484325, createdName=一颗小芃友, createdTime=Sun May 30 17:23:48 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-07-01 146f2fadm18暂无昵称

    不懂mate分析

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1896848, encodeId=9f1c18968484d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon Sep 27 08:49:42 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888304, encodeId=9efb188830446, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon Mar 14 04:49:42 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978618, encodeId=9ab39e8618a1, content=不懂mate分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Thu Jul 01 14:46:39 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554816, encodeId=bb2e155481690, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Tue Jun 01 07:49:42 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969850, encodeId=59549698503f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02972000979, createdName=walking, createdTime=Mon May 31 14:06:45 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969743, encodeId=d247969e435d, content=忘了好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6515442859, createdName=ms2000000817442249, createdTime=Mon May 31 00:27:41 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969661, encodeId=f4b9969661d2, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>欢迎加群一起探讨学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/4dcd194e80b140debd1d7d6c161b3f13/7d140f158faa42adaa5ff6054058df7d.jpg, createdBy=216b5484325, createdName=一颗小芃友, createdTime=Sun May 30 17:23:48 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1896848, encodeId=9f1c18968484d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon Sep 27 08:49:42 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888304, encodeId=9efb188830446, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon Mar 14 04:49:42 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978618, encodeId=9ab39e8618a1, content=不懂mate分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Thu Jul 01 14:46:39 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554816, encodeId=bb2e155481690, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Tue Jun 01 07:49:42 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969850, encodeId=59549698503f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02972000979, createdName=walking, createdTime=Mon May 31 14:06:45 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969743, encodeId=d247969e435d, content=忘了好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6515442859, createdName=ms2000000817442249, createdTime=Mon May 31 00:27:41 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969661, encodeId=f4b9969661d2, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>欢迎加群一起探讨学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/4dcd194e80b140debd1d7d6c161b3f13/7d140f158faa42adaa5ff6054058df7d.jpg, createdBy=216b5484325, createdName=一颗小芃友, createdTime=Sun May 30 17:23:48 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-31 walking

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1896848, encodeId=9f1c18968484d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon Sep 27 08:49:42 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888304, encodeId=9efb188830446, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon Mar 14 04:49:42 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978618, encodeId=9ab39e8618a1, content=不懂mate分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Thu Jul 01 14:46:39 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554816, encodeId=bb2e155481690, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Tue Jun 01 07:49:42 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969850, encodeId=59549698503f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02972000979, createdName=walking, createdTime=Mon May 31 14:06:45 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969743, encodeId=d247969e435d, content=忘了好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6515442859, createdName=ms2000000817442249, createdTime=Mon May 31 00:27:41 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969661, encodeId=f4b9969661d2, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>欢迎加群一起探讨学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/4dcd194e80b140debd1d7d6c161b3f13/7d140f158faa42adaa5ff6054058df7d.jpg, createdBy=216b5484325, createdName=一颗小芃友, createdTime=Sun May 30 17:23:48 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-31 ms2000000817442249

    忘了好久了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1896848, encodeId=9f1c18968484d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Mon Sep 27 08:49:42 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888304, encodeId=9efb188830446, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon Mar 14 04:49:42 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978618, encodeId=9ab39e8618a1, content=不懂mate分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d3b5179404, createdName=146f2fadm18暂无昵称, createdTime=Thu Jul 01 14:46:39 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554816, encodeId=bb2e155481690, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Tue Jun 01 07:49:42 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969850, encodeId=59549698503f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02972000979, createdName=walking, createdTime=Mon May 31 14:06:45 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969743, encodeId=d247969e435d, content=忘了好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6515442859, createdName=ms2000000817442249, createdTime=Mon May 31 00:27:41 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969661, encodeId=f4b9969661d2, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>欢迎加群一起探讨学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/4dcd194e80b140debd1d7d6c161b3f13/7d140f158faa42adaa5ff6054058df7d.jpg, createdBy=216b5484325, createdName=一颗小芃友, createdTime=Sun May 30 17:23:48 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-30 一颗小芃友

    #梅斯医学科研互助群#欢迎加群一起探讨学习

    0

相关资讯

JNNP:抗Aβ药物治疗轻中度阿尔茨海默病的系统回顾和meta分析

阿尔茨海默病(AD)在临床症状出现前几十年,伴随着淀粉样β(Aβ)肽斑块的沉积,这些斑块聚集在皮层和海马体。在早期阶段停止或逆转病理生理过程是晚期阶段的首选策略。在过去的20年中,

Translational Psychiatry:杏仁核功能障碍可能与边缘性人格障碍发病机制有关

杏仁核功能障碍可能代表了边缘性人格障碍一种很有前途的病理生理机制,是一种新的治疗策略的良好靶点,然而,相反,它也可能是情绪处理和调节困难的辅助诊断标志物。

Critical Reviews in Food Science and Nutrition:古法饮食对代谢紊乱有益

古法饮食改善了代谢紊乱患者的胰岛素水平和HDL-C,降低了胰岛素抵抗、血压、TC、LDL-C、TG和CRP水平。

Psychol Med:体素meta分析成人成瘾在反应抑制过程中神经活动的改变

成瘾患者在非成瘾相关刺激的反应抑制任务中,FPN、VAN和小脑的激活发生了改变。虽然FPN和VAN的活性较低,但小脑的活性较强。这些结果可能有助于理解成瘾反应抑制的神经病理学。

今晚19:00直播:潘岳松副研究员:如何评价系统综述与Meta分析

👉 扫描海报二维码0元报名,还能抽领《系统评价、Meta-分析设计与实施方法》纸质书1本

JNNP:颅脑损伤对儿童神经认知功能影响的系统评价和Meta分析

每年影响全球每年有300万儿童新发创伤性脑损伤(TBI),这是导致儿童死亡和残疾的主要原因。 患有中度至重度TBI的儿童伴有终生残疾,影响儿童的教育,就业和心理。